These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11544955)

  • 21. Significant growth in access to HIV treatment in 2006.
    Saudi Med J; 2007 Nov; 28(11):1767-70. PubMed ID: 18213927
    [No Abstract]   [Full Text] [Related]  

  • 22. Antiretroviral therapy adherence in children: outcomes from Africa.
    Reddi A; Leeper SC
    AIDS; 2008 Apr; 22(7):906-7. PubMed ID: 18427213
    [No Abstract]   [Full Text] [Related]  

  • 23. Steady growth in antiretroviral treatment provision by disease management and community treatment programmes.
    Johnson LF; McLeod HD
    S Afr Med J; 2007 May; 97(5):358-9. PubMed ID: 17599217
    [No Abstract]   [Full Text] [Related]  

  • 24. [Highly active antiretroviral therapy with nevirapine. Therapy compliance determines success].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():64-7. PubMed ID: 11373787
    [No Abstract]   [Full Text] [Related]  

  • 25. Social health inequalities during the course of chronic HIV disease in the era of highly active antiretroviral therapy.
    Dray-Spira R; Lert F
    AIDS; 2003 Feb; 17(3):283-90. PubMed ID: 12556681
    [No Abstract]   [Full Text] [Related]  

  • 26. Inequalities in health: access to treatment for HIV/AIDS.
    Giuliano M; Vella S
    Ann Ist Super Sanita; 2007; 43(4):313-6. PubMed ID: 18209264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.
    Reddi A; Leeper SC; Grobler AC; Geddes R; France KH; Dorse GL; Vlok WJ; Mntambo M; Thomas M; Nixon K; Holst HL; Karim QA; Rollins NC; Coovadia HM; Giddy J
    BMC Pediatr; 2007 Mar; 7():13. PubMed ID: 17367540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hopes interrupted: accessing and experiences of antiretroviral therapy in South Africa.
    Fried J; Harris B; Eyles J
    Sex Transm Infect; 2012 Mar; 88(2):147-51. PubMed ID: 22345030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Socioeconomic disparities in access to HIV/AIDS treatment programs in resource-limited settings.
    Tsai AC; Chopra M; Pronyk PM; Martinson NA
    AIDS Care; 2009 Jan; 21(1):59-63. PubMed ID: 18780194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MSF again paves the way with ART.
    Bateman C
    S Afr Med J; 2013 Jan; 103(2):71-3. PubMed ID: 23374312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural barriers to adherence to antiretroviral therapy in a resource-constrained setting: the perspectives of health care providers.
    Coetzee B; Kagee A; Vermeulen N
    AIDS Care; 2011 Feb; 23(2):146-51. PubMed ID: 21259126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender differences in experiences of ART services in South Africa: a mixed methods study.
    Schneider H; Govender V; Harris B; Cleary S; Moshabela M; Birch S
    Trop Med Int Health; 2012 Jul; 17(7):820-6. PubMed ID: 22594691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiretroviral therapy in South Africa--can we do it?
    Bekker LG; Wood R
    S Afr Med J; 2002 Mar; 92(3):191-3. PubMed ID: 12040936
    [No Abstract]   [Full Text] [Related]  

  • 34. Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world.
    Wood E; Montaner JS; Bangsberg DR; Tyndall MW; Strathdee SA; O'Shaughnessy MV; Hogg RS
    AIDS; 2003 Nov; 17(17):2419-27. PubMed ID: 14600512
    [No Abstract]   [Full Text] [Related]  

  • 35. Interventions to reduce mortality in sub-Saharan Africa among HIV-infected adults not yet on antiretroviral therapy.
    Peterson K; van Griensven J; Huis in 't Veld D; Colebunders R
    Expert Rev Anti Infect Ther; 2012 Jan; 10(1):43-50. PubMed ID: 22149613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is antiretroviral therapy cost-effective in South Africa?
    Braithwaite RS; Tsevat J
    PLoS Med; 2006 Jan; 3(1):e60. PubMed ID: 16435892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New trends in HIV disease worldwide.
    Laurence J
    AIDS Read; 2003 Dec; 13(12):569-70. PubMed ID: 14959689
    [No Abstract]   [Full Text] [Related]  

  • 38. Pediatric highly active antiretroviral therapy in Africa: potential benefits of a family-centered model.
    Reddi A; Leeper SC; Sunpath H
    J Infect Dis; 2008 Sep; 198(6):938-9; author reply 939-40. PubMed ID: 18721063
    [No Abstract]   [Full Text] [Related]  

  • 39. South Africa will not pay for antiretroviral therapy.
    Sidley P
    BMJ; 2001 Jun; 322(7300):1441. PubMed ID: 11408289
    [No Abstract]   [Full Text] [Related]  

  • 40. Researchers examine the benefits of potent antiretroviral therapy and treatment compliance among patients with HIV.
    Insight; 2002; 27(4):115. PubMed ID: 12520987
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.